SHINE New Name Highlights Tech Skills and Multiphase Opportunities
JANESVILLE, Wisconsin – (COMMERCIAL THREAD) – SHINE Medical Technologies LLC today announced that the company has changed its name to SHINE Technologies LLC.
The new name of SHINE highlights the company’s core technological skills, its skilled team, and its focus as a next-generation nuclear technology company. SHINE pursues a four-phase strategy for the development of nuclear fusion technology to achieve its ultimate goal of producing fusion energy. SHINE’s technology is currently being applied to advanced industrial inspection services and medical isotope production, Phases I and II of the company’s four-phase approach, respectively.
“Our long-term goal is to create and deploy systems that produce clean fusion energy, and we continue to move towards this goal by bringing more fusion applications to market in the near term,” said Greg Piefer, Founder and CEO of SHINE. “In addition, our merger with Phoenix earlier this year has strengthened our position by allowing us to integrate a key technological capability that supports our short and long term plans. ”
To learn more from Greg Piefer on the SHINE name change, please follow this link to a video on the company’s new website.
Phoenix marketed Phase I, advanced industrial inspection services, over a decade ago using its fusion-based technology for non-destructive testing. These applications take neutron images or perform other modern materials analysis measurements in detail, ensuring that the quality and safety needs of customers in the aerospace, defense and energy industries are met.
SHINE Phase II involves the application of fusion to the production of medical isotopes. The company plans to produce diagnostic isotopes for heart disease and other applications and produces therapeutic isotopes for certain cancers. SHINE plans to produce these isotopes on a commercial scale at a facility at its Janesville, Wisconsin campus.
“The goal of each phase of our approach is to create social and economic value while building additional capabilities and capabilities, and deepening our scientific understanding of fusion technology as we move towards the production of clean energy, ”Piefer said.
SHINE’s next step will be to explore the use of its technology to recycle phase III nuclear waste. Carbonless nuclear energy currently faces a major political hurdle as it produces radioactive waste, some of which can last for millions of years. If successful, SHINE Phase III is expected to help alleviate this problem by recycling some of this waste and using smelting to shorten the half-life of long-lived waste. Importantly, SHINE’s work in this phase could help fission energy become a more sustainable form of carbon-free energy.
The goal of Phase IV is to generate clean, abundant and affordable fusion energy. SHINE believes that achieving this goal will rely on the strength of its skilled team, including its experience in difficult nuclear technology projects, the breadth of the company’s unique technological capabilities, and expected operational experience. many powerful fusion systems in the field during phase III.
“We are delighted that our new name more clearly reflects our core technology skills, strong team and long-term ambitions,” said Piefer. “SHINE was founded on differentiated technology and a unique, lean and progressive approach to the development of nuclear technology. It’s great to tell the world more about the company we’ve built, with an updated brand that reflects it.
About SHINE Technologies
SHINE is a nuclear technology company committed to improving the lives of people and the planet. The company focuses its fusion-based technology initially on advanced industrial imaging and the production of diagnostic and therapeutic isotopes. These isotopes include molybdenum-99, a diagnostic isotope used to diagnose heart disease, cancer, and other conditions, and lutetium-177, a therapeutic isotope that may improve outcomes in some cancer patients when linked to a cell targeting molecule. SHINE has a long-term strategy to solve some of humanity’s greatest problems, including recycling nuclear waste and producing clean fusion power, in addition to advanced industrial imaging and medical isotopes, by pursuing our vision of progressively broad and impactful uses of fusion technology. . For more information about SHINE, please visit our website at https://www.shinetechnologies.com.